Faculty

Scientific Committee Franco Cavalli, Chair, Oncology Institute of Southern Switzerland, Bellinzona CH Alberto Costa, ESO Director, Bellinzona CH and Milano IT Martin F. Fey, University Hospital, Berne CH T. Andrew Lister, St. Bartholomew’s Hospital, London UK Bob Lowenberg, Erasmus University Medical Centre, Rotterdam NL Rolf A. Stahel, University Hospital, Zurich CH Pier Luigi Zinzani, Institute of Hematology “L. e A. Seragnoli”, University of Bologna, Bologna IT ` Emanuelel Zucca, Oncology Institute of Southern Switzerland, Bellinzona CH

Faculty James O. Armitage, University of Nebraska Medical Center, Department of Oncology and Hematology, Omaha US Tiziano Barbui, Ospedali Riuniti di Bergamo, Division of Haematology, Bergamo IT Franco Cavalli, Oncology Institute of Southern Switzerland, Medical Director, Bellinzona CH Alberto Costa, European School of Oncology, Scientific Director, Bellinzona CH and Milano IT Riccardo Dalla-Favera, Herbert Irving Comprehensive Cancer Center, Columbia University, Department of Pathology and Genetics, New York US Martin H. Dreyling, University Hospital Grosshadern, Department of Haemato-Oncology, Munich DE Andres ´ J.M. Ferreri, San Raffaele Scientific Institute, Department of Oncology, Lymphoid Malignancies Unit, Milano IT Martin F. Fey, University of Berne, Clinic for Medical Oncology, Berne CH Michele Ghielmini, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona CH Mary Gospodarowicz, Princess Margaret Hospital − University of Toronto, Department of Radiation Oncology, Toronto CA Michael Hallek, University Clinic Cologne, Department of Haematology, Cologne DE Peter W.M. Johnson, Southampton General Hospital, Cancer Research UK Centre, Somers Cancer Research, Southampton UK T. Andrew Lister, St. Bartholomew’s Hospital, Department of Medical Oncology, London UK Bob Lowenberg, Erasmus University Medical Centre, Department of Haematology, Rotterdam NL Antonio Palumbo, University of Turin, Molinette Hospital, Department of Haematology, Torino IT Maurilio Ponzoni, San Raffaele Scientific Institute, Pathology Unit, Milano IT Gilles Salles, Centre Hospitalier Lyon Sud, Department of Haematology, Lyon Pierre Benite FR Rolf A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich CH Catherine Thieblemont, Saint Louis Hospital, Department of Haemato-Oncology, Paris FR Umberto Vitolo, Ospedale Maggiore S. Giovanni Battista, Haematology Unit, Torino IT Pier Luigi Zinzani, University of Bologna, Institute of Hematology and Oncology L. & A. Seragnoli, Bologna IT Emanuele Zucca, Oncology Institute of Southern Switzerland, Dept. of Medical Oncology, Bellinzona CH

viii